Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Galirayo who wrote (1670)	4/13/2006 11:15:27 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

Let me know when it closes above 19.60, since then I may get interested, although it is way above MBR.<g> The loss in the last 3Qs has been less than in 2004 & it closed the Yr. with a loss of $1.47/shr vs. $1.60/shr in 2004, however, the EL for 2006 is around $2.09/shr and it will need some good news from TELCITA & TELINTRA Last month the analyst from MER downgraded it & said that he thinks TELCITA wonn't get FDA approval because the current trial designs are flawed & the endpoint will be difficult to hit.He also thinks that the market oppportunity for the drug is not very good. TELCITA is on P1-2a for MDS. The stock didn't do well AHs. The consensus "target" is around 25. It seems that with some good news it could get to the $30 level. It needs to hols its support at 17.75 to 18 bigcharts.marketwatch.com bigcharts.marketwatch.com And as I mentioned to Elisabeth, the LTC isn't "interesting".<g> Message 22316904 Bernard